RP 431
Alternative Names: RP-431Latest Information Update: 22 Feb 2000
At a glance
- Originator Bristol-Myers Squibb
- Class Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 22 Feb 2000 No development reported - Preclinical for Thrombosis diagnosis in USA (unspecified route)
- 10 Mar 1997 Preclinical development for Thrombosis diagnosis in USA (unspecified route)